Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active-controlled, randomized, double-blind study with open-label extension (the EVERGREEN study).
Kim G, Lim S, Kwon HS, Park IB, Ahn KJ, Park CY, Kwon SK, Kim HS, Park SW, Kim SG, Moon MK, Kim ES, Chung CH, Park KS, Kim M, Chung DJ, Lee CB, Kim TH, Lee MK.
Kim G, et al. Among authors: kim sg, kim th, kim m, kim hs, kim es.
Diabetes Obes Metab. 2020 Sep;22(9):1527-1536. doi: 10.1111/dom.14061. Epub 2020 May 29.
Diabetes Obes Metab. 2020.
PMID: 32319168
Free PMC article.
Clinical Trial.